← Leaderboards
Anders Per Hakansson
Cubrc, Inc.
$198,948
Attributed
$397,896
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $198.9K · FY2016–17$200K$150K$100K$50K$0
'16
'17
Funding mix
By agency
NIH$397,896 · 1
By mechanism
R21$397,896 · 1
Top collaborators
- Katie J. Edwards2 shared
Most similar at Cubrc, Inc.
Same institution · by research overlap
- Anne Kathleen Radcliff$23,902,389
- Trudy Hope Grossman$987,469
- Katie J. Edwards$198,948
Others in their field
Top investigators on “Adjuvant”
- Lawrence Corey · Fred Hutchinson Cancer Center$377,142,999
- Norman Wolmark · Nsabp Foundation, Inc.$267,141,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$167,183,168
- David Heimbrook · Leidos Biomedical Research, Inc.$151,668,128
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$131,206,481
- Peter B. Gilbert · Fred Hutchinson Cancer Center$117,668,001
Research focus
AdjuvantAdjuvant TherapyAdvanced DevelopmentAnti-Bacterial AgentsAntibiotic ResistanceAntibioticsAntibiotic TherapyAntimicrobialAntimicrobial DrugAntimicrobial ResistanceAreaBacteriaBacterial ResistanceBacterial VectorBactericideBaseBeta-LactamsBiological ModelsBiomassBurden Of IllnessCalciumCell Culture TechniquesCessation Of LifeChemosensitization